We present a case of acute lithium intoxication in a 51-year-old woman on chronic lithium therapy. Her serum lithium level was 10.6 mmol/l 13 hours after ingestion and 5.8 mmol/l at 24 hours. Dialysis therapy was not employed and she recovered well after fluid resuscitation. Serum lithium levels in chronic intoxication are more indicative of intracellular lithium concentration and therefore of clinical toxicity, as opposed to serum lithium levels in acute intoxication. Clinical features of toxicity are more important than a spot lithium level. A combination of clinical toxicity, the duration of exposure and a serial profile of serum lithium levels should guide dialytic therapy for removal of lithium.
Lithium toxicity is becoming more common 1 . With even moderate elevations of serum lithium, patients on long-term therapy are at greater risk for manifesting severe lithium toxicity compared with patients with acute intoxication at similar lithium levels. The serum lithium level of an acute lithium overdose patient does not correlate with tissue lithium levels as well as a serum lithium level seen in a patient on long-term therapy or in chronic lithium toxicity. Accordingly, clinical toxicity may be observed with lower lithium levels in chronic ingestion compared with acute lithium toxicity.
There are no randomized studies to guide the management of lithium toxicity and the indications for haemodialysis are less clear for patients with acute lithium toxicity. We report a patient with acute lithium intoxication who was managed without dialysis. When deciding whether to initiate haemodialysis, the intensivist must not rely solely on isolated serum lithium level but on a combination of clinical features of toxicity, the duration of exposure and serial lithium levels.
CASE HISTORY
A 51-year-old woman presented after suicidal lithium intoxication. She had a history of bipolar affective disorder with depression and had recently been commenced on lithium. Her other medications were fluoxetine and risperidone. A month after commencing lithium, her serum lithium level was 0.5 mmol/l (therapeutic range 0.4 to 0.8). Her lithium dose remained constant for the next two months.
She ingested 50 x450 mg slow-release lithium carbonate tablets after a domestic argument. She was seen at the emergency department of another hospital with the complaints of nausea and headache. Clinical examination was normal and serum electrolytes, urea and creatinine were unremarkable. The emergency department physician administered oral activated charcoal and commenced her on intravenous 0.9% saline infusion. A good diuresis was established. Her serial serum lithium levels are shown in Figure 1 .
Her nausea improved over 12 hours but she complained of persistent mild headache. As the serum lithium level was 10.6 mmol/l 13 hours after ingestion she was referred to our intensive care unit. On transfer, she complained of mild headache but
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Anaesthesia and Intensive Care, Vol. 30, No. 1, February 2002 clinical examination was normal. Specifically there were no features of neurotoxicity or nephrotoxicity. She was managed with 0.9% saline 100 ml/h and this established a good diuresis. Haemodiafiltration was considered but not employed. Her serum lithium level fell to 7.7 mmol/l at 17 hours after ingestion and to 5.8 mmol/l at 24 hours after ingestion. Her headache resolved with time. Saline infusion was stopped and she returned to normal diet and fluids before counselling and discharge. There have been no delayed effects of lithium intoxication and her lithium therapy has been recommenced successfully.
DISCUSSION
As the number of patients on lithium therapy is increasing, lithium toxicity has become more common 1 . Many patients on therapeutic doses of lithium experience side-effects including poor memory, impaired concentration, fatigue and weakness 1 . Features of severe clinical toxicity may be neurological (tremor, apathy, muscle weakness, ataxia, hyperreflexia, stupor, seizures and coma) or gastroenterological (nausea, vomiting and diarrhoea) [1] [2] [3] . Renal tubular dysfunction is also common with severe lithium toxicity 1 but there is no evidence for glomerular dysfunction or progressive renal failure.
In recent times, there has been an increase in the frequency of deliberate acute overdose 2 . In the past, the majority of fatal exposures involved patients on long-term maintenance therapy 3 , but currently patients with intentional acute intoxication account for most of the fatal exposures 4 . There is insufficient data on possible relationship between peak lithium levels and death in fatal acute intoxication.
Lithium is minimally protein bound and has an apparent volume of distribution of 0.6 to 0.8 l/kg (very similar to total body water). Its clearance is predominantly renal and the glomerular filtration rate determines the filtration rate of lithium. However 80% of the filtered lithium is reabsorbed in the proximal tubule. Hence drugs such as aminophylline and carbonic anhydrase inhibitors increase lithium excretion by inhibiting reabsorption at the proximal renal tubule. Reabsorption of lithium and hence toxicity are more likely in hyponatremic or volume-depleted patients 1 .
Peak serum levels are seen one to four hours after regular-release tablets and four to six hours after slow-release preparations. The plasma elimination half-life of a single dose of lithium is between 12 and 27 hours 5 and increases with age 6 . Patients on longterm therapy have a longer elimination half-life 7 .
Intoxication with lithium has long been thought to involve three main factors: a high serum lithium concentration or load, the duration of exposure to the increased load, and the individual tolerance of the load 1 . The lithium level in a patient on chronic therapy is a more reliable indicator of intracellular lithium compared to that in a patient after an acute ingestion 8 . There is a higher incidence of clinical effects of toxicity in chronic intoxication than in acute intoxication with similar lithium levels 3 .
After an acute overdose of lithium, symptoms may be mild despite high serum lithium levels because of the slow distribution phase 9 . On the other hand, serious clinical toxicity has been reported at seemingly therapeutic levels of lithium 10 , but only in patients with chronic lithium intoxication. Interpretation of the serum lithium level following an acute suicidal ingestion is thus difficult, as there is often little correlation between serum lithium levels and clinical toxicity. This highlights the pitfalls of basing therapeutic decisions solely on the lithium level. However, most of the guidelines for managing high serum lithium levels in an intoxicated patient have been derived from studies of toxicity from longterm use 1 .
Gastric emptying with gastric lavage is indicated in acute lithium overdose 11 . Activated charcoal does not bind lithium effectively and is not useful in isolated lithium toxicity 1, 12 . Whole bowel irrigation with a solution of polyethylene glycol is recommended as the decontaminant procedure of choice after acute ingestion of sustained release lithium 13 . Animal and human studies suggest a possible role for polystyrene sulfonate (Kayexalate), a cation exchange resin which, unlike charcoal, binds to lithium favourably 14 .
While gastric decontamination is effective in the early phase, fluid resuscitation and enhanced renal elimination are the mainstays in the management of lithium toxicity 3 .
In normal individuals, renal lithium clearance has been reported to be 10 to 40 ml/min 15 . Sodium and water deficits and renal impairment lead to a decrease in lithium elimination. Forced saline diuresis does not increase lithium excretion and should not be used 3 . Diuretics are not helpful and are potentially dangerous. Some have advocated the use of forced alkaline diuresis, aminophylline, mannitol or sodium bicarbonate. These agents inhibit reabsorption of lithium after glomerular filtration but there are no controlled studies to document their benefit 1 .
While peritoneal dialysis has been used, its clearance is poor compared to haemodiafiltration 16 or haemodialysis 2 , both of which consistently increase lithium ion clearance.
There are no randomized placebo-controlled studies addressing the need for dialytic therapy. Most of the recommendations for haemodialysis arise from studies in chronic intoxication and are not based on hard evidence. Many have recommended haemodialysis if the serum lithium level is >4 mmol/l 11, 17 , even if asymptomatic. While it is true that in chronic intoxication high levels correlate better with clinical toxicity, such recommendations are not evidence based.
Currently there is limited data on the management of high lithium levels after acute ingestion and the wisdom and optimal timing of haemodialysis in acute toxicity are not entirely clear.
Acute ingestion of lithium with high blood levels does not necessarily correlate with significant clinical toxicity nor with poor outcome. In acute intoxication, as our patient illustrates, dialysis therapy need not be embarked upon purely on the basis of lithium levels. Given the pharmacokinetics of lithium and the ease of lithium removal, dialytic therapy has become popular; but merely an isolated serum lithium level should not guide the intensivist. The decision to institute dialysis should be based on a combination of clinical toxicity, the duration of exposure and a serial profile of serum lithium levels.
